Position in CLDX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$75,247,028
+$21,701,322 QoQ
Shares Held
2,022,226
+19.8% QoQ
Ownership
2.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 252 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. CLDX ranks #61 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CLDX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,247,028 | 2,022,226 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $53,545,706 | 1,688,074 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,203,687 | 1,627,529 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $42,611,408 | 1,647,136 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $34,045,142 | 1,672,980 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $28,854,978 | 1,589,806 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $38,787,326 | 1,534,916 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $52,362,036 | 1,540,513 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $56,771,710 | 1,533,956 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $59,361,444 | 1,414,378 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $44,339,642 | 1,117,994 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $27,531,696 | 1,000,425 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $32,744,926 | 965,073 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $33,306,973 | 925,708 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,379,154 | 883,535 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,969,565 | 852,706 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,676,703 | 841,124 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $29,138,772 | 855,513 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,314,628 | 810,420 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $42,787,452 | 792,507 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $22,503,381 | 672,948 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,265,558 | 352,697 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,239,426 | 299,054 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,820,638 | 257,629 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,693,081 | 130,237 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $172,611 | 103,983 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||